nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—AKT1—penis—type 1 diabetes mellitus	0.0268	0.0931	CbGeAlD
Arsenic trioxide—JUN—peripheral nervous system—type 1 diabetes mellitus	0.0138	0.0477	CbGeAlD
Arsenic trioxide—AKT1—nerve—type 1 diabetes mellitus	0.0123	0.0427	CbGeAlD
Arsenic trioxide—JUN—nerve—type 1 diabetes mellitus	0.0107	0.0372	CbGeAlD
Arsenic trioxide—CCND1—islet of Langerhans—type 1 diabetes mellitus	0.00849	0.0294	CbGeAlD
Arsenic trioxide—CCND1—retina—type 1 diabetes mellitus	0.00726	0.0252	CbGeAlD
Arsenic trioxide—MAPK1—islet of Langerhans—type 1 diabetes mellitus	0.00716	0.0248	CbGeAlD
Arsenic trioxide—CCND1—nephron tubule—type 1 diabetes mellitus	0.00684	0.0237	CbGeAlD
Arsenic trioxide—TXNRD1—islet of Langerhans—type 1 diabetes mellitus	0.00666	0.0231	CbGeAlD
Arsenic trioxide—CCND1—cardiovascular system—type 1 diabetes mellitus	0.00614	0.0213	CbGeAlD
Arsenic trioxide—CCND1—kidney—type 1 diabetes mellitus	0.00601	0.0208	CbGeAlD
Arsenic trioxide—AKT1—islet of Langerhans—type 1 diabetes mellitus	0.00597	0.0207	CbGeAlD
Arsenic trioxide—CCND1—pancreas—type 1 diabetes mellitus	0.00597	0.0207	CbGeAlD
Arsenic trioxide—MAPK1—nephron tubule—type 1 diabetes mellitus	0.00576	0.02	CbGeAlD
Arsenic trioxide—TXNRD1—retina—type 1 diabetes mellitus	0.00569	0.0197	CbGeAlD
Arsenic trioxide—MAPK3—retina—type 1 diabetes mellitus	0.00541	0.0188	CbGeAlD
Arsenic trioxide—TXNRD1—nephron tubule—type 1 diabetes mellitus	0.00536	0.0186	CbGeAlD
Arsenic trioxide—JUN—islet of Langerhans—type 1 diabetes mellitus	0.0052	0.018	CbGeAlD
Arsenic trioxide—MAPK1—cardiovascular system—type 1 diabetes mellitus	0.00517	0.0179	CbGeAlD
Arsenic trioxide—CCND1—lymphoid tissue—type 1 diabetes mellitus	0.00516	0.0179	CbGeAlD
Arsenic trioxide—AKT1—retina—type 1 diabetes mellitus	0.00511	0.0177	CbGeAlD
Arsenic trioxide—MAPK3—nephron tubule—type 1 diabetes mellitus	0.0051	0.0177	CbGeAlD
Arsenic trioxide—MAPK1—kidney—type 1 diabetes mellitus	0.00506	0.0176	CbGeAlD
Arsenic trioxide—MAPK1—pancreas—type 1 diabetes mellitus	0.00503	0.0174	CbGeAlD
Arsenic trioxide—TXNRD1—cardiovascular system—type 1 diabetes mellitus	0.00482	0.0167	CbGeAlD
Arsenic trioxide—TXNRD1—kidney—type 1 diabetes mellitus	0.00471	0.0163	CbGeAlD
Arsenic trioxide—TXNRD1—pancreas—type 1 diabetes mellitus	0.00468	0.0162	CbGeAlD
Arsenic trioxide—MAPK3—cardiovascular system—type 1 diabetes mellitus	0.00458	0.0159	CbGeAlD
Arsenic trioxide—MAPK3—kidney—type 1 diabetes mellitus	0.00448	0.0155	CbGeAlD
Arsenic trioxide—MAPK3—pancreas—type 1 diabetes mellitus	0.00445	0.0154	CbGeAlD
Arsenic trioxide—JUN—retina—type 1 diabetes mellitus	0.00444	0.0154	CbGeAlD
Arsenic trioxide—MAPK1—lymphoid tissue—type 1 diabetes mellitus	0.00435	0.0151	CbGeAlD
Arsenic trioxide—AKT1—cardiovascular system—type 1 diabetes mellitus	0.00432	0.015	CbGeAlD
Arsenic trioxide—AKT1—kidney—type 1 diabetes mellitus	0.00423	0.0147	CbGeAlD
Arsenic trioxide—AKT1—pancreas—type 1 diabetes mellitus	0.0042	0.0146	CbGeAlD
Arsenic trioxide—JUN—nephron tubule—type 1 diabetes mellitus	0.00419	0.0145	CbGeAlD
Arsenic trioxide—TXNRD1—lymphoid tissue—type 1 diabetes mellitus	0.00405	0.014	CbGeAlD
Arsenic trioxide—MAPK3—lymphoid tissue—type 1 diabetes mellitus	0.00385	0.0133	CbGeAlD
Arsenic trioxide—JUN—cardiovascular system—type 1 diabetes mellitus	0.00376	0.013	CbGeAlD
Arsenic trioxide—IKBKB—cardiovascular system—type 1 diabetes mellitus	0.00374	0.013	CbGeAlD
Arsenic trioxide—JUN—kidney—type 1 diabetes mellitus	0.00368	0.0128	CbGeAlD
Arsenic trioxide—JUN—pancreas—type 1 diabetes mellitus	0.00365	0.0127	CbGeAlD
Arsenic trioxide—AKT1—lymphoid tissue—type 1 diabetes mellitus	0.00363	0.0126	CbGeAlD
Arsenic trioxide—JUN—lymphoid tissue—type 1 diabetes mellitus	0.00316	0.011	CbGeAlD
Arsenic trioxide—IKBKB—lymphoid tissue—type 1 diabetes mellitus	0.00314	0.0109	CbGeAlD
Arsenic trioxide—ABCC2—nephron tubule—type 1 diabetes mellitus	0.00228	0.0079	CbGeAlD
Arsenic trioxide—CYP1B1—nephron tubule—type 1 diabetes mellitus	0.00223	0.00774	CbGeAlD
Arsenic trioxide—CYP1B1—cardiovascular system—type 1 diabetes mellitus	0.002	0.00695	CbGeAlD
Arsenic trioxide—ABCC2—kidney—type 1 diabetes mellitus	0.002	0.00694	CbGeAlD
Arsenic trioxide—CYP1B1—kidney—type 1 diabetes mellitus	0.00196	0.0068	CbGeAlD
Arsenic trioxide—CYP1B1—lymphoid tissue—type 1 diabetes mellitus	0.00168	0.00584	CbGeAlD
Arsenic trioxide—CYP1A1—kidney—type 1 diabetes mellitus	0.00139	0.00481	CbGeAlD
Arsenic trioxide—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00102	0.00353	CbGeAlD
Arsenic trioxide—CYP3A4—kidney—type 1 diabetes mellitus	0.00102	0.00353	CbGeAlD
Arsenic trioxide—ABCB1—retina—type 1 diabetes mellitus	0.00087	0.00302	CbGeAlD
Arsenic trioxide—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000819	0.00284	CbGeAlD
Arsenic trioxide—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000736	0.00255	CbGeAlD
Arsenic trioxide—ABCB1—kidney—type 1 diabetes mellitus	0.00072	0.0025	CbGeAlD
Arsenic trioxide—ABCB1—pancreas—type 1 diabetes mellitus	0.000715	0.00248	CbGeAlD
Arsenic trioxide—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000618	0.00214	CbGeAlD
Arsenic trioxide—MAPK1—Disease—CCR5—type 1 diabetes mellitus	2.46e-05	3.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.42e-05	3.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.41e-05	3.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.41e-05	3.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EGFR—type 1 diabetes mellitus	2.41e-05	3.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HLA-A—type 1 diabetes mellitus	2.4e-05	3.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—GCG—type 1 diabetes mellitus	2.39e-05	3.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD80—type 1 diabetes mellitus	2.38e-05	3.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-DRB1—type 1 diabetes mellitus	2.38e-05	3.34e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—type 1 diabetes mellitus	2.37e-05	3.34e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—type 1 diabetes mellitus	2.37e-05	3.33e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.36e-05	3.31e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.35e-05	3.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.35e-05	3.3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.34e-05	3.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD80—type 1 diabetes mellitus	2.31e-05	3.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.3e-05	3.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—type 1 diabetes mellitus	2.3e-05	3.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EGFR—type 1 diabetes mellitus	2.29e-05	3.22e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EGFR—type 1 diabetes mellitus	2.28e-05	3.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—GCG—type 1 diabetes mellitus	2.28e-05	3.21e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.28e-05	3.2e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-DRB1—type 1 diabetes mellitus	2.27e-05	3.19e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS2—type 1 diabetes mellitus	2.26e-05	3.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.23e-05	3.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.23e-05	3.13e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.2e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.2e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD80—type 1 diabetes mellitus	2.2e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS2—type 1 diabetes mellitus	2.2e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD80—type 1 diabetes mellitus	2.2e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CD86—type 1 diabetes mellitus	2.19e-05	3.08e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EGFR—type 1 diabetes mellitus	2.19e-05	3.08e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.19e-05	3.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—type 1 diabetes mellitus	2.18e-05	3.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CAT—type 1 diabetes mellitus	2.18e-05	3.06e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.17e-05	3.05e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ITPR3—type 1 diabetes mellitus	2.16e-05	3.04e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.13e-05	3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.13e-05	3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD80—type 1 diabetes mellitus	2.13e-05	2.99e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.13e-05	2.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—type 1 diabetes mellitus	2.13e-05	2.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.12e-05	2.98e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CD86—type 1 diabetes mellitus	2.11e-05	2.96e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—type 1 diabetes mellitus	2.11e-05	2.96e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD80—type 1 diabetes mellitus	2.1e-05	2.95e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—TYK2—type 1 diabetes mellitus	2.09e-05	2.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS2—type 1 diabetes mellitus	2.09e-05	2.94e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.08e-05	2.93e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—INS—type 1 diabetes mellitus	2.08e-05	2.92e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.07e-05	2.91e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.05e-05	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CD86—type 1 diabetes mellitus	2.04e-05	2.87e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HBA1—type 1 diabetes mellitus	2.04e-05	2.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.03e-05	2.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD80—type 1 diabetes mellitus	2.03e-05	2.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—type 1 diabetes mellitus	2.03e-05	2.85e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOC3—type 1 diabetes mellitus	2.02e-05	2.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.02e-05	2.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.01e-05	2.83e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—INS—type 1 diabetes mellitus	2.01e-05	2.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—TYK2—type 1 diabetes mellitus	2.01e-05	2.82e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—E2F1—type 1 diabetes mellitus	2e-05	2.81e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTT1—type 1 diabetes mellitus	1.99e-05	2.79e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.98e-05	2.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.98e-05	2.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IFNG—type 1 diabetes mellitus	1.96e-05	2.75e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	1.96e-05	2.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—TYK2—type 1 diabetes mellitus	1.95e-05	2.74e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.95e-05	2.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.95e-05	2.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.94e-05	2.73e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—type 1 diabetes mellitus	1.94e-05	2.72e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.93e-05	2.72e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.92e-05	2.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—INS—type 1 diabetes mellitus	1.92e-05	2.69e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—type 1 diabetes mellitus	1.91e-05	2.68e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.9e-05	2.67e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD4—type 1 diabetes mellitus	1.89e-05	2.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IFNG—type 1 diabetes mellitus	1.88e-05	2.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.87e-05	2.63e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CD86—type 1 diabetes mellitus	1.86e-05	2.62e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—type 1 diabetes mellitus	1.86e-05	2.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TYK2—type 1 diabetes mellitus	1.85e-05	2.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TYK2—type 1 diabetes mellitus	1.85e-05	2.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—type 1 diabetes mellitus	1.85e-05	2.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.85e-05	2.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.84e-05	2.59e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.84e-05	2.59e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	1.84e-05	2.59e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.83e-05	2.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.83e-05	2.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IFNG—type 1 diabetes mellitus	1.82e-05	2.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS3—type 1 diabetes mellitus	1.82e-05	2.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD4—type 1 diabetes mellitus	1.82e-05	2.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.81e-05	2.55e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.8e-05	2.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TYK2—type 1 diabetes mellitus	1.8e-05	2.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.79e-05	2.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.77e-05	2.49e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TYK2—type 1 diabetes mellitus	1.77e-05	2.49e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.77e-05	2.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS3—type 1 diabetes mellitus	1.77e-05	2.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—type 1 diabetes mellitus	1.76e-05	2.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD4—type 1 diabetes mellitus	1.76e-05	2.48e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—type 1 diabetes mellitus	1.76e-05	2.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.75e-05	2.47e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—type 1 diabetes mellitus	1.75e-05	2.45e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL2—type 1 diabetes mellitus	1.74e-05	2.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—INS—type 1 diabetes mellitus	1.74e-05	2.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IFNG—type 1 diabetes mellitus	1.74e-05	2.44e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	1.73e-05	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.73e-05	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TYK2—type 1 diabetes mellitus	1.71e-05	2.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.7e-05	2.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.69e-05	2.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—type 1 diabetes mellitus	1.69e-05	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS3—type 1 diabetes mellitus	1.68e-05	2.36e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.68e-05	2.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—type 1 diabetes mellitus	1.68e-05	2.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD4—type 1 diabetes mellitus	1.68e-05	2.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD4—type 1 diabetes mellitus	1.68e-05	2.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL2—type 1 diabetes mellitus	1.67e-05	2.35e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IFNG—type 1 diabetes mellitus	1.66e-05	2.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.65e-05	2.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—type 1 diabetes mellitus	1.64e-05	2.3e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.63e-05	2.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—type 1 diabetes mellitus	1.63e-05	2.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD4—type 1 diabetes mellitus	1.63e-05	2.29e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.63e-05	2.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL2—type 1 diabetes mellitus	1.62e-05	2.28e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.62e-05	2.27e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD4—type 1 diabetes mellitus	1.6e-05	2.25e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CD80—type 1 diabetes mellitus	1.6e-05	2.25e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.6e-05	2.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ALB—type 1 diabetes mellitus	1.59e-05	2.24e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.59e-05	2.23e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GCG—type 1 diabetes mellitus	1.58e-05	2.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—type 1 diabetes mellitus	1.56e-05	2.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—type 1 diabetes mellitus	1.55e-05	2.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD4—type 1 diabetes mellitus	1.55e-05	2.17e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL2—type 1 diabetes mellitus	1.54e-05	2.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.54e-05	2.16e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—NOS3—type 1 diabetes mellitus	1.52e-05	2.14e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—INS—type 1 diabetes mellitus	1.51e-05	2.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.49e-05	2.1e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—type 1 diabetes mellitus	1.49e-05	2.09e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—type 1 diabetes mellitus	1.48e-05	2.08e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL2—type 1 diabetes mellitus	1.48e-05	2.07e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—STAT3—type 1 diabetes mellitus	1.46e-05	2.06e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.46e-05	2.06e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—INS—type 1 diabetes mellitus	1.45e-05	2.04e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—INS—type 1 diabetes mellitus	1.44e-05	2.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.42e-05	1.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—INS—type 1 diabetes mellitus	1.41e-05	1.98e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—STAT3—type 1 diabetes mellitus	1.41e-05	1.98e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.41e-05	1.98e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.4e-05	1.97e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.39e-05	1.95e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.38e-05	1.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—STAT3—type 1 diabetes mellitus	1.36e-05	1.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.36e-05	1.92e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CD80—type 1 diabetes mellitus	1.36e-05	1.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.36e-05	1.91e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.35e-05	1.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—INS—type 1 diabetes mellitus	1.34e-05	1.88e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CAT—type 1 diabetes mellitus	1.34e-05	1.88e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—type 1 diabetes mellitus	1.33e-05	1.87e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.33e-05	1.86e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ALB—type 1 diabetes mellitus	1.32e-05	1.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.3e-05	1.82e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—STAT3—type 1 diabetes mellitus	1.3e-05	1.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—STAT3—type 1 diabetes mellitus	1.3e-05	1.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.3e-05	1.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.29e-05	1.81e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—INS—type 1 diabetes mellitus	1.28e-05	1.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—type 1 diabetes mellitus	1.28e-05	1.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.27e-05	1.79e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NOS3—type 1 diabetes mellitus	1.27e-05	1.78e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.26e-05	1.78e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.26e-05	1.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.26e-05	1.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—STAT3—type 1 diabetes mellitus	1.26e-05	1.77e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—STAT3—type 1 diabetes mellitus	1.24e-05	1.74e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.24e-05	1.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—type 1 diabetes mellitus	1.24e-05	1.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.24e-05	1.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.2e-05	1.68e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—STAT3—type 1 diabetes mellitus	1.2e-05	1.68e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—type 1 diabetes mellitus	1.18e-05	1.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—type 1 diabetes mellitus	1.18e-05	1.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.18e-05	1.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.15e-05	1.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—type 1 diabetes mellitus	1.14e-05	1.61e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—type 1 diabetes mellitus	1.13e-05	1.59e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.13e-05	1.58e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.13e-05	1.58e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—type 1 diabetes mellitus	1.12e-05	1.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—type 1 diabetes mellitus	1.09e-05	1.53e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.08e-05	1.52e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.08e-05	1.52e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.08e-05	1.51e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.07e-05	1.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.06e-05	1.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.05e-05	1.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.05e-05	1.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.04e-05	1.47e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—type 1 diabetes mellitus	1.02e-05	1.44e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1e-05	1.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.99e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—type 1 diabetes mellitus	9.97e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	9.96e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.92e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—type 1 diabetes mellitus	9.82e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	9.78e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.55e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—type 1 diabetes mellitus	9.54e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—type 1 diabetes mellitus	9.53e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.46e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.09e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—type 1 diabetes mellitus	9.07e-06	1.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—type 1 diabetes mellitus	9.06e-06	1.27e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—INS—type 1 diabetes mellitus	8.9e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.82e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—type 1 diabetes mellitus	8.8e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—type 1 diabetes mellitus	8.67e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.6e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.39e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—type 1 diabetes mellitus	8.37e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.26e-06	1.16e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALB—type 1 diabetes mellitus	8.16e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.03e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.01e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NOS3—type 1 diabetes mellitus	7.8e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	7.79e-06	1.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.63e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.3e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—INS—type 1 diabetes mellitus	7.11e-06	9.99e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—type 1 diabetes mellitus	6.61e-06	9.29e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	6.6e-06	9.27e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	6.52e-06	9.16e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—type 1 diabetes mellitus	6.35e-06	8.92e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	6.23e-06	8.76e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—type 1 diabetes mellitus	6.16e-06	8.66e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.86e-06	8.24e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—type 1 diabetes mellitus	5.61e-06	7.88e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	4.38e-06	6.15e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	4.01e-06	5.64e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.84e-06	5.4e-06	CbGpPWpGaD
